MiCoBio India Private Limited, a subsidiary of South Korea’s MiCo BioMed, was founded in November 2022 with the mission to revolutionize healthcare through innovative in vitro diagnostic (IVD) technologies. The company specializes in Hemoglobin detection and Lipid profiling, providing advanced, user-friendly meters designed for contamination-free and efficient operation. By focusing on Point of Care diagnostic solutions, MiCoBio India serves hospitals, healthcare institutions, labs, and consumers with early detection tools for regular health tracking.

With a state-of-the-art manufacturing facility equipped with modern, fully automated machines sourced from Korea, MiCoBio India ensures the production of high-quality diagnostic products. The company’s rigorous quality control and in-house testing processes guarantee product excellence, supported by a team of experienced professionals dedicated to innovation. As a fast-growing player in India’s POCT (Point of Care Testing) market, MiCoBio India has established a strong reputation for excellence and customer satisfaction.